Leslie G. Ford

Research interests

Publications

• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5

• Repurposing metformin for the prevention of cancer and cancer recurrence

  Diabetologia · 2017 · https://doi.org/10.1007/s00125-017-4372-6

• Prevention and early detection of prostate cancer

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6

• Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders

  Cancer Prevention Research · 2014 · https://doi.org/10.1158/1940-6207.capr-13-0424

• Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60140-3

• Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.49.3122

• Vitamin E and the Risk of Prostate Cancer

  JAMA · 2011 · https://doi.org/10.1001/jama.2011.1437

• Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

  JAMA · 2008 · https://doi.org/10.1001/jama.2008.864

• Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa031918

• The Influence of Finasteride on the Development of Prostate Cancer

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa030660

• Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk

  JNCI Journal of the National Cancer Institute · 1999 · https://doi.org/10.1093/jnci/91.19.1654

Current projects

No projects listed.